Seizure News and Research

Latest Seizure News and Research

Shots are nothing to shy away from with the right approach

"Getting shots may seem burdensome and even downright scary to some children, but they protect children against dangerous and deadly diseases."

28 Aug 2008

High cholesterol levels drop naturally in children on high-fat antiseizure diet

Elevated cholesterol levels return to normal or near normal levels over time in four out of 10 children with uncontrollable epilepsy treated with the high-fat ketogenic diet, according to results of a Johns Hopkins Children's Center study reported in the Journal of Child Neurology.

26 Aug 2008

New model for studying the genetics of Angelman syndrome

A model for studying the genetics of Angelman syndrome, a neurological disorder that causes mental retardation and other symptoms in one out of 15,000 births, has been developed by biologists at The University of Texas at Austin.

14 Aug 2008

Managing diabetes at school

The first ever UK study to seek the opinions of young people with type 1 diabetes, regarding managing their diabetes care at school, uncovered a number of significant misconceptions about the condition.

14 Aug 2008

Anti-reflux surgery - research may lead to changes in treatment recommendations

Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.

4 Aug 2008

Desmopressin for bed-wetting linked to convulsions in children

Australian authorities have issued a warning regarding a drug sometimes used to treat primary nocturnal enuresis (bed-wetting) in children.

3 Aug 2008

Variation in TNFAIP3 gene - cutting the brakes on the immune system

Your immune system may have more in common with a Corvette than you thought. When a virus or bacteria enters a human body, the immune system revs up to fight and expel the invader. Once the invader is gone, the body puts on the brakes to stop the immune response.

3 Aug 2008

FDA seizes more than $24 Million in unapproved new drugs

Representatives of the U.S. Food and Drug Administration and the U.S. Marshals Service today seized $24.2 million worth of unapproved new drugs from KV Pharmaceutical Company of St. Louis, Mo. Agents acted after United States Attorney Catherine L. Hanaway filed a civil forfeiture suit and obtained a warrant to seize the unapproved new drug products being made by KV Pharmaceutical.

30 Jul 2008

FDA approves first generic divalproex sodium for the treatment of seizures, bipolar disorder and migraine headaches

The U.S. Food and Drug Administration today approved the first generic versions of Depakote delayed-release tablets (divalproex sodium). Depakote is approved by the FDA for the treatment of seizures, bipolar disorder and migraine headaches.

29 Jul 2008

U.S. authorities seize Xiadafil VIP tablets after company refuses to recall product

At the request of the U.S. Food and Drug Administration, U.S. Marshals seized nearly $74,000 worth of Xiadafil VIP tablets, Lots 6K029 and 6K209-SEI, distributed by SEI Pharmaceuticals, Inc. of Miami, Fla. Although marketed as a dietary supplement to treat erectile dysfunction (ED) and for sexual enhancement, these lots represent an illegally marketed drug containing an undeclared ingredient.

24 Jul 2008

Epilepsy drug may raise the risk of birth defects

Scientists have found that women who take an epilepsy drug while they are pregnant may increase the risk of birth defects in their babies.

22 Jul 2008

Taking the epilepsy drug topiramate may increase risk of birth defects

Taking the epilepsy drug topiramate alone or along with other epilepsy drugs during pregnancy may increase the risk of birth defects, according to a study published in the July 22, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.

21 Jul 2008

Hormesis deserves the respect and attention of toxicologists

A comprehensive review published in Environmental Toxicology and Chemistry argues that toxicologists can positively affect public health and reduce the economic costs of drug treatment by increasing their knowledge of hormesis and applying its principles to their discipline.

17 Jul 2008

Depression after stroke: a neglected problem

People who have had a stroke and the people who are close to them need more support in order to manage the consequences of stroke.

10 Jul 2008

Discovery of new function for an old enzyme in sialidosis

The lack of a single protein usually thought of as a run-of-the-mill enzyme that helps to recycle molecules in cells causes an incurable and often fatal disease of children, according to St. Jude Children's Research Hospital investigators.

7 Jul 2008

Seizures in newborns can be detected with bedside brain-activity monitors

Compact, bedside brain-activity monitors detected most seizures in at-risk infants, researchers at Washington University School of Medicine in St. Louis showed. That means the compact units could assist clinicians in monitoring for electrical seizures until confirmation with conventional EEG (electroencephalography), the researchers assert in an article published in the June issue of Pediatrics.

2 Jul 2008

Neural stem cell development may be linked to Autism

In a breakthrough scientific study published today in the Proceedings of the National Academy of Sciences, scientists at the Burnham Institute for Medical Research have shown that neural stem cell development may be linked to Autism.

30 Jun 2008

Watson Pharmaceuticals launches generic version of dronabinol

Watson Pharmaceuticals, Inc. has announced that, under a supply agreement with Solvay Pharmaceuticals, Inc., Watson has launched the authorized generic version of dronabinol in the 2.5, 5 and 10 mg once daily dosage strengths.

30 Jun 2008

FDA approves Kinrix - combination vaccine for diphtheria, tetanus, pertussis and polio diseases in one shot

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine], the first combination vaccine to offer protection against diphtheria, tetanus, pertussis and polio diseases in one shot.

24 Jun 2008

Discovery of potential key to better drugs to fight Toxoplasmosis parasite

Discoveries by IU School of Medicine scientists have opened a promising door to new drugs for toxoplasmosis and other parasites that now can evade treatments by turning dormant in the body.

19 Jun 2008